Mark Coleman insider trades
Open-market stock purchases and sales by Mark Coleman, Unknown at Axsome Therapeutics, Inc, from SEC Form 4 filings since Nov 19, 2015.
Track record: 100% of 5 scored buys are up 5% or more since purchase, averaging +149%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 10, 2026 | AXSM Axsome Therapeutics, Inc | Sold | $160K |
| Jun 8, 2026 | AXSM Axsome Therapeutics, Inc | Bought (not open market) | — |
| Jun 5, 2026 | AXSM Axsome Therapeutics, Inc | Bought (not open market) | — |
| Jun 2, 2026 | AXSM Axsome Therapeutics, Inc | Sold | $1.2M |
| Jun 1, 2026 | AXSM Axsome Therapeutics, Inc | Sold | $1.4M |
| May 29, 2026 | AXSM Axsome Therapeutics, Inc | Sold | $1.4M |
| Feb 26, 2026 | AXSM Axsome Therapeutics, Inc | Sold | $4M |
| Feb 23, 2026 | AXSM Axsome Therapeutics, Inc | Bought (not open market) | — |
| Feb 20, 2026 | AXSM Axsome Therapeutics, Inc | Bought (not open market) | — |
| Feb 10, 2026 | AXSM Axsome Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- AXSM Axsome Therapeutics, Inc: 11 buys, 12 sales, last Jun 10, 2026